- Lyme disease is a tick-borne illness caused by bacteria called Borrelia burgdorferi. Lyme disease is transmitted to humans through a bite of an infected black legged tick. The infection spreads through the blood stream causing wide range of symptoms depending upon the stages. Lyme disease is a contagious disease that shows common indications or symptoms like redness, fatigue, skin rashes and other flu-like symptoms.
- The demand for Lyme disease drugs is significantly driven by the rising prevalence of Lyme disease and advancements in treatment options.
- North America is expected to dominate the Lyme Disease Drug s market due to advanced healthcare infrastructure and increasing demand for lyme disease
- Asia-Pacific is expected to be the fastest growing region in the Lyme Disease Drug market during the forecast period due to rising awareness about lyme health
- The Lyme disease treatment segment is expected to dominate the market, driven by the high prevalence of the disease and the increasing demand for effective therapies. As the primary approach to managing Lyme disease, advancements in diagnostic and treatment technologies are enhancing patient outcomes.
